Warning letter
First Pharma Associates LLC dba Riverpoint Pharmacy: warning letter of Sep 12, 2017
FDA warning letter 522020 · Los Angeles District Office
Key facts
| Reference number | 522020 |
|---|---|
| Company | First Pharma Associates LLC dba Riverpoint Pharmacy |
| Subject | Compounding Pharmacy/Adulterated Drug Products |
| Issue date | Sep 12, 2017 |
| Posted date | Sep 21, 2017 |
| Issuing office | Los Angeles District Office |
| Product type | Drugs |
| CFR sections cited | 201.115 |
| Inspection city | Spokane |
| Inspection ZIP | 99205-4528 |
| Inspection start date | Dec 6, 2016 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: